Local funding crisis threatens U.S. vaccine rollout By Carl O'Donnell and Rebecca Spalding FILE PHOTO: Pfizer-BioNTech coronavirus disease (COVID-19) vaccination in New York NEW YORK (Reuters) -Seattle public health officials have so little COVID-19 funding on hand they worry they will have to shut down some virus testing sites as they mount a campaign to dose their 2.3 million residents with Pfizer Inc’s and Moderna Inc’s vaccines. King County, which represents greater Seattle, has $14 million of COVID-19 funding for 2021, roughly enough to fund its operations for a single month, and a fraction of the $87 million emergency COVID-19 aid it received in 2020, said Ingrid Ulrey, the public health policy director for King County.